Methemoglobin (Capillary Blood)

This test measures the proportion of your hemoglobin that is in the methemoglobin form, which cannot carry oxygen normally. It is performed on a small capillary blood sample, typically taken from a fingertip or heel, and analyzed using a co-oximeter that distinguishes methemoglobin from other hemoglobin types.

Methemoglobin can form after exposure to certain medicines or chemicals, or because of inherited conditions that affect red blood cells. The result reflects how much of your total hemoglobin is affected at the time of sampling.

When methemoglobin levels rise, oxygen delivery to tissues can drop, leading to symptoms such as gray or blue skin color, headache, fatigue, dizziness, or shortness of breath. Clinicians order this test when oxygen readings do not match how you look or feel, after exposure to potential oxidant drugs or chemicals, or when a congenital cause is suspected.

The result helps confirm methemoglobinemia and guides treatment decisions, such as stopping an offending agent, providing supportive care, or considering specific antidotal therapy. It is also useful for monitoring recovery and for assessing vulnerable groups like newborns or people with certain enzyme deficiencies or hemoglobin variants.

Your care team will interpret your methemoglobin result together with your symptoms, vital signs, and exposure history. A small increase may resolve on its own once the source is removed, while more marked elevations, especially with symptoms, usually require urgent treatment and close monitoring.

If you have conditions like glucose-6-phosphate dehydrogenase deficiency or hemoglobin variants, the approach to therapy may differ, and your clinician will choose options that are safest for you. Follow-up testing may be done to confirm improvement after treatment or after stopping the suspected exposure. Seek urgent care if you develop worsening shortness of breath, confusion, or increasing discoloration of the skin or lips.